Default: Bone Marrow Transplantation

ISSN: 0268-3369

Journal Home

Journal Guideline

Bone Marrow Transplantation Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Bone Marrow Transplantation is a journal indexed in SJR in Hematology and Transplantation with an H index of 144. It has a price of 3580 €. It has an SJR impact factor of 1,318 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,318.

Bone Marrow Transplantation focuses its scope in these topics and keywords: cell, stem, allogeneic, hematopoietic, transplantation, patients, blood, transplant, peripheral, conditioning, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


3580 €

Inmediate OA


Embargoed OA

0 €

Non OA


Bone Marrow Transplantation


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

cell, stem, allogeneic, hematopoietic, transplantation, patients, blood, transplant, peripheral, conditioning, outcomes, leukemia, disease, autologous, myeloid, marrow, model, gcsf, chemotherapy, graftversushost, lymphoma,

Best articles by citations

Monitoring four herpesviruses in unrelated cord blood transplantation

View more

Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients

View more

A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation

View more

Development of a district Cord Blood Bank: a model for cord blood banking in the National Health Service

View more

Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience

View more

Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT

View more

Phialophora verrucosa infection in a BMT patient

View more

Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation

View more

Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

View more

No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients

View more

Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections

View more

Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients

View more

Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature

View more

Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients

View more

Neosartorya fischeri: an invasive fungal pathogen in an allogeneic bone marrow transplant patient

View more

Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery

View more

Antibody and pre- plus post-transplant prednisone treatments support T cell-depleted stem cell engraftment without drug-induced morbidity

View more

Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant

View more

Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT

View more

Mucormycosis of the vulva following bone marrow transplantation

View more

Acute pneumatosis cystoides intestinalis following allogeneic transplantation -the surgeon's dilemma

View more

Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

View more

Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy

View more

Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies

View more